Shimony S., Stahl M., Stone R.M. 2023. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 98, 502–526. https://doi.org/10.1002/ajh.26822

Article  PubMed  Google Scholar 

Kantarjian H., Borthakur G., Daver N., DiNardo C.D., Issa G., Jabbour E., Kadia T., Sasaki K., Short N.J., Yilmaz M., Ravandi F. 2024. Current status and research directions in acute myeloid leukemia. Blood Cancer J. 14, 163. https://doi.org/10.1038/s41408-024-01143-2

Article  PubMed  PubMed Central  Google Scholar 

Culver-Cochran A.E., Hassan A., Hueneman K., Choi K., Ma A., VanCauwenbergh B., O’Brien E., Wunderlich M., Perentesis J.P., Starczynowski D.T. 2024. Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis. Nat. Commun. 15, 9189. https://doi.org/10.1038/s41467-024-53629-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hagiya A., Vaidya P., Khedro T., Yaghmour B., Siddiqi I., Yaghmour G. 2019. Bone marrow features in patients with acute myeloid leukemia treated with novel targeted isocitrate dehydrogenase 1/2 inhibitors. World J. Oncol. 10, 226–230. https://doi.org/10.14740/wjon1231

Article  PubMed  PubMed Central  Google Scholar 

Tuzuner N., Cox C., Rowe J.M., Bennett J.M. 1994. Bone marrow cellularity in myeloid stem cell disorders: Impact of age correction. Leuk. Res. 18, 559–564. https://doi.org/10.1016/0145-2126(94)90036-1

Article  CAS  PubMed  Google Scholar 

Chen M., Kim Y., Huang Q., Chang K., Gaal K.K., Weiss L.M. 2011. Acute myeloid leukemia with an unusual histologic pattern mimicking metastatic carcinoma in bone marrow: A diagnostic pitfall. J. Hematopathol. 4, 117–122. https://doi.org/10.1007/s12308-011-0090-z

Article  Google Scholar 

Helbig D., Quesada A.E., Xiao W., Roshal M., Tallman M.S., Knorr D.A. 2020. Spontaneous remission in a patient with acute myeloid leukemia leading to undetectable minimal residual disease. J. Hematol. 9, 18–22. https://doi.org/10.14740/jh606

Article  PubMed  PubMed Central  Google Scholar 

Islam A. 2024. AML-097 induction treatment of acute myeloid leukemia in an elderly patient with intra-marrow injection of cytarabine (Ara-C). Clin. Lymphoma Myeloma Leuk. 24, 293. https://doi.org/10.1016/S2152-2650(24)01158-3

Article  Google Scholar 

Vucetic M., Daher B., Cassim S., Meira W., Pouyssegur J. 2020. Together we stand, apart we fall: How cell-to-cell contact/interplay provides resistance to ferroptosis. Cell Death Dis. 11, 789. https://doi.org/10.1038/s41419-020-02994-w

Article  PubMed  PubMed Central  Google Scholar 

Gujral T.S., Kirschner M.W. 2017. Hippo pathway mediates resistance to cytotoxic drugs. Proc. Natl. Acad. Sci. USA. 114, E3729–E3738. https://doi.org/10.1073/pnas.1703096114

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kobyakova M., Lomovskaya Y., Senotov A., Lomovsky A., Minaychev V., Fadeeva I., Shtatnova D., Krasnov K., Zvyagina A., Odinokova I., Akatov V., Fadeev R. 2022. The increase in the drug resistance of acute myeloid leukemia THP-1 cells in high-density cell culture is associated with inflammatory-like activation and anti-apoptotic Bcl-2 proteins. Int. J. Mol. Sci. 23, 7881. https://doi.org/10.3390/ijms23147881

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kobyakova M., Lomovskaya Y., Senotov A., Lomovsky A., Minaichev V., Zvyagina A., Solovieva M., Fadeeva I., Akatov V., Fadeev R. 2021. Appearance of signs of differentiation and pro-inflammatory phenotype in acute myeloid leukemia cells THP-1 with an increase in their TRAIL resistance in cell aggregates in vitro. Biochem. (Moscow) Suppl. Ser. A, Membr. Cell Biol. 15, 97–105. https://doi.org/10.1134/S1990747821010050

Article  CAS  Google Scholar 

Azharuddin M., Roberg K., Dhara A.K., Jain M.V., Darcy P., Hinkula J., Slater N.K.H., Patra H.K. 2019. Dissecting multi drug resistance in head and neck cancer cells using multicellular tumor spheroids. Sci. Rep. 9, 20066. https://doi.org/10.1038/s41598-019-56273-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sayo K., Aoki S., Kojima N. 2016. Fabrication of bone marrow-like tissue in vitro from dispersed-state bone marrow cells. Regen. Ther. 3, 32–37. https://doi.org/10.1016/j.reth.2016.01.008

Article  PubMed  PubMed Central  Google Scholar 

Kobyakova M., Senotov A., Krasnov K., Lomovskaya Y., Odinokova I., Kolotova A., Ermakov A., Zvyagina A., Fadeeva I., Fetisova E., Akatov V., Fadeev R. 2024. Pro-inflammatory activation suppresses TRAIL-induced apoptosis of acute myeloid leukemia cells. Biochemistry (Moscow). 89, 431–440. https://doi.org/10.1134/S0006297924030040

Article  CAS  PubMed  Google Scholar 

Ueno M., Kakinuma Y., Yuhki K., Murakoshi N., Iemitsu M., Miyauchi T., Yamaguchi I. 2006. Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. J. Pharmacol. Sci. 101, 151–158. https://doi.org/10.1254/jphs.fp0050980

Article  CAS  PubMed  Google Scholar 

Gomes M.T., Palasiewicz K., Gadiyar V., Lahey K., Calianese D., Birge R.B., Ucker D.S. 2022. Phosphatidylserine externalization by apoptotic cells is dispensable for specific recognition leading to innate apoptotic immune responses. J. Biol. Chem. 298, 102034. https://doi.org/10.1016/j.jbc.2022.102034

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grantab R., Sivananthan S., Tannock I.F. 2006. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res. 66, 1033–1039. https://doi.org/10.1158/0008-5472.CAN-05-3077

Article  CAS  PubMed  Google Scholar 

Nowacka M., Sterzynska K., Andrzejewska M., Nowicki M., Januchowski R. 2021. Drug resistance evaluation in novel 3D in vitro model. Biomed. Pharmacother. 138, 111536. https://doi.org/10.1016/j.biopha.2021.111536

Article  CAS  PubMed  Google Scholar 

Duchrow M., Schlüter C., Key G., Kubbutat M.H., Wohlenberg C., Flad H.D., Gerdes J. 1995. Cell proliferation-associated nuclear antigen defined by antibody Ki-67: A new kind of cell cycle-maintaining proteins. Arch. Immunol. Ther. Exp. 43, 117–121.

CAS  Google Scholar 

Srivastava R.K., Sasaki C.Y., Hardwick J.M., Longo D.L. 1999. Bcl-2-mediated drug resistance: Inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J. Exp. Med. 190, 253–265. https://doi.org/10.1084/jem.190.2.253

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raisova M., Hossini A.M., Eberle J., Riebeling C., Wieder T., Sturm I., Daniel P.T., Orfanos C.E., Geilen C.C. 2001. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J. Invest. Dermatol. 117, 333–340. https://doi.org/10.1046/j.0022-202x.2001.01409.x

Article  CAS  PubMed  Google Scholar 

Rajput D., Naval R., Yadav K., Tungaria A., Behari S. 2010. Bilateral proptosis and bitemporal swelling: A rare manifestation of acute myeloid leukemia. J. Pediatr. Neurosci. 5, 68–71. https://doi.org/10.4103/1817-1745.66687

Article  PubMed  PubMed Central  Google Scholar 

Choi C.H. 2005. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int. 5, 30. https://doi.org/10.1186/1475-2867-5-30

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salvia A.M., Cuviello F., Coluzzi S., Nuccorini R., Attolico I., Pascale S.P., Bisaccia F., Pizzuti M., Ostuni A. 2017. Expression of some ATP-binding Cassette transporters in acute myeloid leukemia. Hematol. Rep. 9, 7406. https://doi.org/10.4081/hr.2017.7406

Article  CAS  PubMed  PubMed Central  Google Scholar 

Callaghan R., Luk F., Bebawy M. 2014. Inhibition of the multidrug resistance P-glycoprotein: Time for a change of strategy? Drug Metab. Dispos. 42, 623–631. https://doi.org/10.1124/dmd.113.056176

Article  CAS  PubMed  PubMed Central  Google Scholar